Literature DB >> 28710302

A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome.

Martina Soldarini1, Lucia Farina2, Augusto Genderini3, Niccolo Bolli1.   

Abstract

Chronic lymphocytic leukaemia (CLL) is characterised by a lymphocytosis of mature-appearing clonal CD5+, CD23+ B lymphocytes. CLL cells arise from the bone marrow and infiltrate lymphoid tissues such as lymph nodes and spleen. Presentation is usually through discovery of lymphocytosis or lymphadenopathy. Unusual presentations, especially paraneoplastic syndromes are rare. Here, we describe a rare case presenting with severe nephrotic syndrome associated with the presence of a monoclonal protein in serum. Workup for suspected plasma cell dyscrasia led instead to the diagnosis of bone marrow infiltration by atypical CLL without lymphocytosis. Renal biopsy showed a glomerulonephritis that turned out to be paraneoplastic as it went into remission after treatment for CLL. Our case shows an unusual presentation of CLL and prompts for increased awareness of lymphoproliferative disorders in the context of seemingly unrelated conditions that may be paraneoplastic in origin. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (drugs and medicines); nephrotic syndrome

Mesh:

Year:  2017        PMID: 28710302      PMCID: PMC5534686          DOI: 10.1136/bcr-2016-218850

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

1.  Paraneoplastic glomerulopathies: new insights into an old entity.

Authors:  P M Ronco
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

2.  Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients.

Authors:  N Da'as; A Polliack; Y Cohen; G Amir; D Darmon; Y Kleinman; A W Goldfarb; D Ben-Yehuda
Journal:  Eur J Haematol       Date:  2001-09       Impact factor: 2.997

3.  Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia.

Authors:  N Yahata; Y Kawanishi; S Okabe; Y Kimura; T Okada; M Otani; T Shimizu; T Nakao; K Ohyashiki
Journal:  Am J Nephrol       Date:  2000 Sep-Oct       Impact factor: 3.754

4.  Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects.

Authors:  Meritxell Garcia Alzamora; Markus Schmidli; Urs Hess; Richard Cathomas; Roger von Moos
Journal:  Onkologie       Date:  2006-03-22

5.  Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.

Authors:  C Bartel; N Obermüller; M J Rummel; H Geiger; I A Hauser
Journal:  Clin Nephrol       Date:  2008-04       Impact factor: 0.975

6.  Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.

Authors:  Prudence A Hill; Frank Firkin; Karen M Dwyer; Petrova Lee; Brendan F Murphy
Journal:  Pathology       Date:  2002-04       Impact factor: 5.306

7.  Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas.

Authors:  B Moulin; P M Ronco; B Mougenot; A Francois; J P Fillastre; F Mignon
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

Review 8.  Nephrotic syndrome in chronic lymphocytic leukemia: a paraneoplastic syndrome?

Authors:  N Aslam; N I Nseir; J F Viverett; S I Bastacky; J P Johnson
Journal:  Clin Nephrol       Date:  2000-12       Impact factor: 0.975

Review 9.  Autoimmune complications of chronic lymphocytic leukemia.

Authors:  Terry J Hamblin
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

10.  International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.

Authors:  A C Rawstron; N Villamor; M Ritgen; S Böttcher; P Ghia; J L Zehnder; G Lozanski; D Colomer; C Moreno; M Geuna; P A S Evans; Y Natkunam; S E Coutre; E D Avery; L Z Rassenti; T J Kipps; F Caligaris-Cappio; M Kneba; J C Byrd; M J Hallek; E Montserrat; P Hillmen
Journal:  Leukemia       Date:  2007-03-15       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.